Vimarsana
Biggest News Aggregation in the World

Page 22 - Device Designation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Device Designation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Device Designation Today - Breaking & Trending Today

Synchron Raises $75M in Series C Funding - Vimarsana News

Synchron Raises $75M in Series C Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Cardiosense, Inc., Completes $15.1 Million Series A Financing to Advance Artificial Intelligence Platform for Heart Disease - Vimarsana News

Cardiosense, Inc., Completes $15.1 Million Series A Financing to Advance Artificial Intelligence Platform for Heart Disease

/PRNewswire/ -- Cardiosense, Inc., a Chicago-based digital health company leveraging artificial intelligence and multi-sensor devices to enable early detection...

Cardiosense, Inc., Completes $15.1 Million Series A Financing to Advance Artificial Intelligence Platform for Heart Disease - Vimarsana News

Cardiosense, Inc., Completes $15.1 Million Series A Financing to Advance Artificial Intelligence Platform for Heart Disease

/PRNewswire/ -- Cardiosense, Inc., a Chicago-based digital health company leveraging artificial intelligence and multi-sensor devices to enable early detection...

Biological Dynamics announces prospective clinical trial, ExoLuminate™ - Vimarsana News

Biological Dynamics announces prospective clinical trial, ExoLuminate™

/PRNewswire/ -- Biological Dynamics, a company developing its exosome-isolation ExoVerita™ platform for early disease diagnostics, announced today it has...

Biological Dynamics announces prospective clinical trial, ExoLuminate™ - Vimarsana News

Biological Dynamics announces prospective clinical trial, ExoLuminate™

Study to demonstrate its proprietary test's effectiveness for early detection of pancreatic cancerSAN DIEGO, Dec. 1, 2022 /PRNewswire/ -- Biologic...